453 related articles for article (PubMed ID: 12702044)
1. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
[TBL] [Abstract][Full Text] [Related]
2. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
3. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
4. [Barrett's esophagus: diagnosis and therapy].
Schmassmann A; Gebbers JO
Praxis (Bern 1994); 2005 May; 94(21):861-8. PubMed ID: 15966485
[TBL] [Abstract][Full Text] [Related]
5. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
6. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?
Ortner MA
Curr Gastroenterol Rep; 2001 Oct; 3(5):371-4. PubMed ID: 11560793
[No Abstract] [Full Text] [Related]
10. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology.
Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ
Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766
[TBL] [Abstract][Full Text] [Related]
11. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of the diagnosis of dysplasia in Barrett's esophagus.
Ofman JJ; Lewin K; Ramers C; Ippoliti A; Lieberman D; Weinstein W
Am J Gastroenterol; 2000 Oct; 95(10):2946-52. PubMed ID: 11051373
[TBL] [Abstract][Full Text] [Related]
13. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.
Gossner L; May A; Stolte M; Seitz G; Hahn EG; Ell C
Gastrointest Endosc; 1999 Jan; 49(1):8-12. PubMed ID: 9869716
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus.
Falk GW
Gastrointest Endosc Clin N Am; 1994 Oct; 4(4):773-89. PubMed ID: 7812646
[TBL] [Abstract][Full Text] [Related]
15. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
[TBL] [Abstract][Full Text] [Related]
16. A surveillance programme for Barrett's oesophagus in a UK general hospital.
Olithselvan A; Gorard DA; McIntyre AS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.
Ghaus S; Neumann H; Muhammad H; Tontini GE; Ishaq S
Dig Dis Sci; 2016 Aug; 61(8):2185-2193. PubMed ID: 27038446
[TBL] [Abstract][Full Text] [Related]
18. The value of medical imaging in uncomplicated and complicated Barrett's esophagus.
De Backer AI; De Schepper AM; Pelckmans P
Acta Gastroenterol Belg; 2000; 63(1):22-8. PubMed ID: 10907315
[TBL] [Abstract][Full Text] [Related]
19. Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival.
Aldulaimi DM; Cox M; Nwokolo CU; Loft DE
Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):943-50. PubMed ID: 16093872
[TBL] [Abstract][Full Text] [Related]
20. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.
Peters JH; Clark GW; Ireland AP; Chandrasoma P; Smyrk TC; DeMeester TR
J Thorac Cardiovasc Surg; 1994 Nov; 108(5):813-21; discussion 821-2. PubMed ID: 7967662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
